Larimar Therapeutics, Inc. · NASDAQ:LRMR

Clayton Russell bought 3,322 Larimar Therapeutics, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Clayton Russell (Chief Medical Officer) bought 3,322 Larimar Therapeutics, Inc. shares at US$3.01 for US$9,999, leaving 74,765 shares. Filed Nov 18, 2026 (Form 4).

Bought
3,322 shares
Price
US$3.01
Value
US$9,999
Holding after
74,765 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockBuy3,322US$3.0174,765Direct

Source

Download original · View original at SEC

Related